News

The partnership extends the compatibility of Sequel’s Twiist system to allow people with Type 1 diabetes to pair the device ...
Sequel’s twiist will become the first automated insulin delivery system to integrate with Senseonics' one-year CGM system.
Senseonics and newcomer pump developer Sequel Med Tech have a plan to connect their diabetes technologies, with the goal of ...
Sequel Med Tech and Senseonics today announced a commercial development agreement to combine insulin delivery and glucose ...
AID system compatible with Senseonics Eversense® 365 one-year CGM system twiist with Eversense 365 launch expected in Q3 ...